...
首页> 外文期刊>Neurobiology of Aging: Experimental and Clinical Research >Depressed contractile function and adrenergic responsiveness of cardiac myocytes in an experimental model of Parkinson disease, the MPTP-treated mouse.
【24h】

Depressed contractile function and adrenergic responsiveness of cardiac myocytes in an experimental model of Parkinson disease, the MPTP-treated mouse.

机译:在MPTP治疗的帕金森病实验模型中,心肌细胞的收缩功能和肾上腺素能反应性下降。

获取原文
获取原文并翻译 | 示例
           

摘要

Radiotracer and biochemical studies have shown that patients with Parkinson disease lack functional sympathetic innervation to the heart. The same observation was made in mice treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), an experimental model of Parkinson disease. This study examined the mechanical properties, adrenergic receptor level and intracellular Ca(2+) handling in cardiac myocytes isolated from C57/BL6 mice that received either MPTP (30mg/kg, i.p., twice in 24h) or vehicle. Mechanical properties were evaluated using an IonOptix MyoCam(R) system. Myocytes were electrically stimulated at 0.5Hz. The contractile properties analyzed included peak shortening (PS), time-to-PS (TPS), time-to-90% relengthening (TR(90)), and maximal velocities of shortening and relengthening (+/-dL/dt). Intracellular Ca(2+) handling was evaluated with fura 2. Myocytes from MPTP-treated mice exhibited a depressed PS (85% of normal), normal TPS, prolonged TR(90) (147% of normal), and reduced +/-dL/dt (both 79% of normal). These results were correlated with a 67% reduction of beta-adrenergic receptor expression in myocardial membranes from MPTP-treated mice when compared to normal. Myocytes from MPTP-treated mice also exhibited a reduced peak of intracellular Ca(2+) sequestration and sarcoplasmic reticulum (SR) Ca(2+) load (55 and 38% of normal, respectively). The resting intracellular Ca(2+) and Ca(2+)-transient decay were comparable to the values seen in myocytes from untreated mice. Myocytes from MPTP-treated and untreated mice were equally responsive over a range of stimulation frequencies (0.1, 0.5, 1, 3 and 5Hz). Response to norepinephrine (1microM) and isoproterenol (1microM) was reduced in myocytes from MPTP-treated mice. These results demonstrate substantial cardiac dysfunctions in this model of experimental Parkinson disease, probably due to reduced adrenergic responsiveness and SR Ca(2+) load.
机译:放射性示踪剂和生化研究表明,帕金森病患者缺乏对心脏的功能性交感神经。在用1-甲基-4-苯基-1,2,3,6-四氢吡啶(MPTP)(帕金森氏病的实验模型)治疗的小鼠中也得到了相同的观察结果。这项研究检查了从接受MPTP(30mg / kg,i.p.,24h两次)或赋形剂的C57 / BL6小鼠分离的心肌细胞中的机械性能,肾上腺素能受体水平和细胞内Ca(2+)处理。使用IonOptix MyoCam系统评估机械性能。以0.5Hz电刺激心肌细胞。分析的收缩特性包括峰缩短(PS),到达PS的时间(TPS),达到90%的延长时间(TR(90))和缩短和延长的最大速度(+/- dL / dt)。用呋喃2评估细胞内Ca(2+)的处理。来自MPTP处理的小鼠的心肌细胞表现出PS降低(正常值的85%),TPS正常,TR(90)延长(正常值147%)和+/-降低dL / dt(均为正常值的79%)。这些结果与MPTP处理小鼠的心肌膜中的β-肾上腺素能受体表达降低67%有关。从MPTP处理的小鼠的心肌细胞还表现出减少的细胞内Ca(2+)螯合和肌浆网(SR)Ca(2+)负载的峰值(分别为正常的55%和38%)。静止的细胞内Ca(2+)和Ca(2+)瞬态衰减与未经处理的小鼠的肌细胞中看到的值相当。 MPTP处理和未处理小鼠的心肌细胞在一系列刺激频率(0.1、0.5、1、3和5Hz)上具有同等反应。 MPTP处理的小鼠的肌细胞对去甲肾上腺素(1microM)和异丙肾上腺素(1microM)的反应降低。这些结果表明这种实验性帕金森病模型中的实质性心脏功能障碍,可能是由于降低的肾上腺素反应性和SR Ca(2+)负荷。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号